The BIO2G project provides a new unique solution for production of the 2nd generation environmental-friendly biofuel (biobutanol) and biosolvents (bioacetone, bioethanol) from lignocellulose raw materials. The BIO2G biorefinery technology is innovative combination of two existing technologies, where the first is pre-treatment of biomass with follow-up production of sugars and second one is ABE technology, for production of biobutanol, bioacetone and bioethanol, where raw materials are C5 and C6 sugars. The new BIO2G technology process is a result of research of the Consortium and is verified on a laboratory prototype. It addresses following problems of the biofuel market: (a) Reduction of GHG emission from transportation, by using of new advanced (2G) biofuel, (b) Substitution of food or feed origin raw materials for biofuels production, by non-food raw materials, thus, fulfilling of EU legislation criteria set for production and using of 2nd generation biofuels (2G). The commercialization of the BIO2G technology will help to reach the RED II targets for 2030. The proposed process innovation has significant economic and societal impact: (a) it creates a new form of agricultural and forest residuals utilization for industrial production and (b) an opportunity for utilizing polluted and low-grated soil for the cultivation of energy plants used for BIO2G technology. These new opportunities enable the utilization of non-food raw materials for BIO2G and shall create a new era of rural development with new farm job opportunities.The research, market and financial data analysis performed by the experts during the Phase 1 BIO2G project were summarized in the Feasibility Study (deliverable of the project). The technology, market, financial and organizational part of the study has demonstrated, that the project is feasible and has set conditions for its success. One of the condition of its feasibility is access to EU funds for the construction of BIO2G pilot plant, updating and verification of technology and its commercialization (preferably from SME Instrument Phase II). The strategic objective is to commercialize a novel 2nd generation biofuels (non-food advanced biofuels), intermediates (C6 and C5 sugars) and by-products (CO2 lignin, DDGS). The REDII has set strict targets for use of advanced biofuels, but without new technology developments the production volumes of advanced biofuels needed cannot be achieved. The technology shall dramatically reduce the carbon footprint of the EU in line with the COP 21 agreement and to meet the environmental goals in the transport (10% biofuel in 2030) and heat sector as well as feedstock of the chemical industry (including cosmetic industry). The company will grow from a project company focused on technology development to a company providing services and bio-technologies to its client network throughout the world. The long-term approach of the implementation strategy will be implemented in three phases (8 years in total): A (PHASE 2): Building the pilot technology verification plant and capabilities for commercialization. B (PHASE 3): Gradual scale-up commercialization of services and products of the technology. C (PHASE 4): Extension of BIO2G technology partner and client network. Large-scale commercialization with in two parallel growth dimensions: 1 (Plan 4A): Innovated pilot verification plant. 2 (Plan 4B): Large scale production plant. Phase-1 involves the Initial BIO2G proposal and processing of this feasibility study.
